GOLDSMITH MARK A sold RVMD
April 15, 2026 · Form 4 insider transaction
GOLDSMITH MARK A sold 120,000 shares of Revolution Medicines, Inc. at $150.09 per share, a transaction worth $18.01M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; This transaction was executed in multiple trades at prices ranging from $150.00 to $150.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.; Includes 201,150 restricted stock units.